Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 262

1.

Prevalence, Incidence, and Clearance of Human Papillomavirus Types Covered by Current Vaccines in Men With Human Immunodeficiency Virus in the SUN Study.

Patel P, Bush T, Conley L, Unger ER, Darragh TM, Henry K, Escota G, Brooks JT, Kojic EM.

J Infect Dis. 2019 Sep 19. pii: jiz425. doi: 10.1093/infdis/jiz425. [Epub ahead of print]

PMID:
31536120
2.

Transgender Women Have Higher Human Papillomavirus Prevalence Than Men Who Have Sex With Men-Two U.S. Cities, 2012-2014.

Singh V, Gratzer B, Gorbach PM, Crosby RA, Panicker G, Steinau M, Amiling R, Unger ER, Markowitz LE, Meites E.

Sex Transm Dis. 2019 Oct;46(10):657-662. doi: 10.1097/OLQ.0000000000001051.

PMID:
31517805
3.

Declines in Vaccine-Type Human Papillomavirus Prevalence in Females Across Racial/Ethnic Groups: Data From a National Survey.

McClung NM, Lewis RM, Gargano JW, Querec T, Unger ER, Markowitz LE.

J Adolesc Health. 2019 Sep 9. pii: S1054-139X(19)30353-2. doi: 10.1016/j.jadohealth.2019.07.003. [Epub ahead of print]

PMID:
31515134
4.

Human Papillomavirus Vaccination for Adults: Updated Recommendations of the Advisory Committee on Immunization Practices.

Meites E, Szilagyi PG, Chesson HW, Unger ER, Romero JR, Markowitz LE.

MMWR Morb Mortal Wkly Rep. 2019 Aug 16;68(32):698-702. doi: 10.15585/mmwr.mm6832a3.

5.

Endometriosis as a Comorbid Condition in Chronic Fatigue Syndrome (CFS): Secondary Analysis of Data From a CFS Case-Control Study.

Boneva RS, Lin JS, Wieser F, Nater UM, Ditzen B, Taylor RN, Unger ER.

Front Pediatr. 2019 May 21;7:195. doi: 10.3389/fped.2019.00195. eCollection 2019.

6.

Declines in HPV vaccine type prevalence in women screened for cervical cancer in the United States: Evidence of direct and herd effects of vaccination.

Markowitz LE, Naleway AL, Lewis RM, Crane B, Querec TD, Weinmann S, Steinau M, Unger ER.

Vaccine. 2019 Jun 27;37(29):3918-3924. doi: 10.1016/j.vaccine.2019.04.099. Epub 2019 May 31.

PMID:
31160099
7.

Pilot study of markers for high-grade anal dysplasia in a southern cohort from the Women's Interagency HIV Study (WIHS).

Lahiri CD, Nguyen ML, Mehta CC, Mosunjac M, Tadros T, Unger ER, Rajeevan MS, Richards J, Ofotokun I, Flowers L.

Clin Infect Dis. 2019 May 6. pii: ciz336. doi: 10.1093/cid/ciz336. [Epub ahead of print]

PMID:
31058984
8.

Long intervals between two doses of HPV vaccines and magnitude of the immune response: a post hoc analysis of two clinical trials.

Gilca V, Sauvageau C, Panicker G, De Serres G, Schiller J, Ouakki M, Unger ER.

Hum Vaccin Immunother. 2019;15(7-8):1980-1985. doi: 10.1080/21645515.2019.1605278. Epub 2019 Jun 3.

PMID:
31017850
9.

Estimated Number of Cases of High-Grade Cervical Lesions Diagnosed Among Women - United States, 2008 and 2016.

McClung NM, Gargano JW, Park IU, Whitney E, Abdullah N, Ehlers S, Bennett NM, Scahill M, Niccolai LM, Brackney M, Griffin MR, Pemmaraju M, Querec TD, Cleveland AA, Unger ER, Markowitz LE; HPV-IMPACT Working Group.

MMWR Morb Mortal Wkly Rep. 2019 Apr 19;68(15):337-343. doi: 10.15585/mmwr.mm6815a1.

10.

Cervical adenocarcinoma in situ: Human papillomavirus types and incidence trends in five states, 2008-2015.

Cleveland AA, Gargano JW, Park IU, Griffin MR, Niccolai LM, Powell M, Bennett NM, Saadeh K, Pemmaraju M, Higgins K, Ehlers S, Scahill M, Johnson Jones ML, Querec T, Markowitz LE, Unger ER; HPV-IMPACT Working Group.

Int J Cancer. 2019 Apr 13. doi: 10.1002/ijc.32340. [Epub ahead of print]

PMID:
30980692
11.

Human papillomavirus DNA detection, p16INK4a, and oral cavity cancer in a U.S. population.

Hernandez BY, Lynch CF, Chan OTM, Goodman MT, Unger ER, Steinau M, Thompson TD, Gillison M, Lyu C, Saraiya M; HPV Typing of Cancer Workgroup.

Oral Oncol. 2019 Apr;91:92-96. doi: 10.1016/j.oraloncology.2019.03.001. Epub 2019 Mar 5.

PMID:
30926069
12.
13.

Trends in Human Papillomavirus Vaccine Types 16 and 18 in Cervical Precancers, 2008-2014.

McClung NM, Gargano JW, Bennett NM, Niccolai LM, Abdullah N, Griffin MR, Park IU, Cleveland AA, Querec TD, Unger ER, Markowitz LE; HPV-IMPACT Working Group.

Cancer Epidemiol Biomarkers Prev. 2019 Mar;28(3):602-609. doi: 10.1158/1055-9965.EPI-18-0885. Epub 2019 Feb 21.

PMID:
30792242
14.

Simultaneous extraction of mRNA and microRNA from whole blood stabilized in tempus tubes.

Richards J, Unger ER, Rajeevan MS.

BMC Res Notes. 2019 Jan 18;12(1):39. doi: 10.1186/s13104-019-4087-5.

15.

Population-Based Assessment of HPV Genotype-Specific Cervical Cancer Survival: CDC Cancer Registry Sentinel Surveillance System.

Hallowell BD, Saraiya M, Thompson TD, Unger ER, Lynch CF, Tucker T, Copeland G, Hernandez BY, Peters ES, Wilkinson E, Goodman MT.

JNCI Cancer Spectr. 2018 Jul;2(3). pii: pky036. doi: 10.1093/jncics/pky036. Epub 2018 Aug 11.

16.

Seroprevalence of Human Papillomavirus 6/11/16/18 Among Self-identified Gay/Bisexual Men Who Have Sex With Men, Men Who Have Sex With Women, and Females, United States, 2003-2010.

Lewis RM, Markowitz LE, Panicker G, Unger ER.

Clin Infect Dis. 2019 Aug 30;69(6):1011-1018. doi: 10.1093/cid/ciy1002.

PMID:
30475987
17.

Results of a Pilot Study of a Mail-Based Human Papillomavirus Self-Testing Program for Underscreened Women From Appalachian Ohio.

Reiter PL, Shoben AB, McDonough D, Ruffin MT, Steinau M, Unger ER, Paskett ED, Katz ML.

Sex Transm Dis. 2019 Mar;46(3):185-190. doi: 10.1097/OLQ.0000000000000944.

PMID:
30461597
18.

Immunogenicity and safety of a mixed vaccination schedule with one dose of nonavalent and one dose of bivalent HPV vaccine versus two doses of nonavalent vaccine - A randomized clinical trial.

Gilca V, Sauvageau C, Panicker G, De Serres G, Ouakki M, Unger ER.

Vaccine. 2018 Nov 12;36(46):7017-7024. doi: 10.1016/j.vaccine.2018.09.057. Epub 2018 Oct 9.

PMID:
30314913
19.

Antibody persistence after a single dose of quadrivalent HPV vaccine and the effect of a dose of nonavalent vaccine given 3-8 years later - an exploratory study.

Gilca V, Sauvageau C, Panicker G, De Serres G, Ouakki M, Unger ER.

Hum Vaccin Immunother. 2019;15(2):503-507. doi: 10.1080/21645515.2018.1522469. Epub 2018 Sep 27.

20.

Risk Factors for Oral Human Papillomavirus Infection Among Young Men Who Have Sex With Men-2 Cities, United States, 2012-2014.

Oliver SE, Gorbach PM, Gratzer B, Steinau M, Collins T, Parrish A, Kerndt PR, Crosby RA, Unger ER, Markowitz LE, Meites E.

Sex Transm Dis. 2018 Oct;45(10):660-665. doi: 10.1097/OLQ.0000000000000845.

PMID:
30204745
21.

Trends in High-grade Cervical Lesions and Cervical Cancer Screening in 5 States, 2008-2015.

Gargano JW, Park IU, Griffin MR, Niccolai LM, Powell M, Bennett NM, Johnson Jones ML, Whitney E, Pemmaraju M, Brackney M, Abdullah N, Scahill M, Dahl RM, Cleveland AA, Unger ER, Markowitz LE; HPV-IMPACT Working Group .

Clin Infect Dis. 2019 Apr 8;68(8):1282-1291. doi: 10.1093/cid/ciy707.

PMID:
30137283
22.

Trends in High-Grade Cervical Cancer Precursors in the Human Papillomavirus Vaccine Era.

Oakley F, Desouki MM, Pemmaraju M, Gargano JM, Markowitz LE, Steinau M, Unger ER, Zhu Y, Fadare O, Griffin MR.

Am J Prev Med. 2018 Jul;55(1):19-25. doi: 10.1016/j.amepre.2018.03.015. Epub 2018 May 16.

PMID:
29778314
23.

Seroprevalence of HPV 6, 11, 16 and 18 and correlates of exposure in unvaccinated women aged 16-64 years in Puerto Rico.

Ortiz AP, Tortolero-Luna G, Romaguera J, Pérez CM, González D, Muñoz C, González L, Marrero E, Suárez E, Palefsky JM, Panicker G, Unger ER.

Papillomavirus Res. 2018 Jun;5:109-113. doi: 10.1016/j.pvr.2018.03.006. Epub 2018 Mar 16.

24.
25.

Association of chronic fatigue syndrome with premature telomere attrition.

Rajeevan MS, Murray J, Oakley L, Lin JS, Unger ER.

J Transl Med. 2018 Feb 27;16(1):44. doi: 10.1186/s12967-018-1414-x.

26.

Prevalence and Incidence of Anal and Cervical High-Risk Human Papillomavirus (HPV) Types Covered by Current HPV Vaccines Among HIV-Infected Women in the SUN Study.

Kojic EM, Conley L, Bush T, Cu-Uvin S, Unger ER, Henry K, Hammer J, Escota G, Darragh TM, Palefsky JM, Brooks JT, Patel P.

J Infect Dis. 2018 Apr 23;217(10):1544-1552. doi: 10.1093/infdis/jiy087.

PMID:
29452366
27.

Immunogenicity of HPV prophylactic vaccines: Serology assays and their use in HPV vaccine evaluation and development.

Pinto LA, Dillner J, Beddows S, Unger ER.

Vaccine. 2018 Aug 6;36(32 Pt A):4792-4799. doi: 10.1016/j.vaccine.2017.11.089. Epub 2018 Feb 1.

28.

Antibody responses among adolescent females receiving two or three quadrivalent human papillomavirus vaccine doses at standard and prolonged intervals.

Widdice LE, Unger ER, Panicker G, Hoagland R, Callahan ST, Jackson LA, Berry AA, Kotloff K, Frey SE, Harrison CJ, Pahud BA, Edwards KM, Mulligan MJ, Sudman J, Bernstein DI.

Vaccine. 2018 Feb 1;36(6):881-889. doi: 10.1016/j.vaccine.2017.12.042. Epub 2018 Jan 3.

29.

Prevalence of Genital Human Papillomavirus Among Sexually Experienced Males and Females Aged 14-59 Years, United States, 2013-2014.

Lewis RM, Markowitz LE, Gargano JW, Steinau M, Unger ER.

J Infect Dis. 2018 Mar 5;217(6):869-877. doi: 10.1093/infdis/jix655.

30.

Prevalence, Incidence, and Clearance of Anal High-Risk Human Papillomavirus Infection Among HIV-Infected Men in the SUN Study.

Patel P, Bush T, Kojic EM, Conley L, Unger ER, Darragh TM, Henry K, Hammer J, Escota G, Palefsky JM, Brooks JT.

J Infect Dis. 2018 Mar 5;217(6):953-963. doi: 10.1093/infdis/jix607.

PMID:
29211874
31.

CDC Activities for Improving Implementation of Human Papillomavirus Vaccination, Cervical Cancer Screening, and Surveillance Worldwide.

Senkomago V, Duran D, Loharikar A, Hyde TB, Markowitz LE, Unger ER, Saraiya M.

Emerg Infect Dis. 2017 Dec;23(13). doi: 10.3201/eid2313.170603. Review.

32.

Serum Immune Profiling for Early Detection of Cervical Disease.

Ewaisha R, Panicker G, Maranian P, Unger ER, Anderson KS.

Theranostics. 2017 Aug 23;7(16):3814-3823. doi: 10.7150/thno.21098. eCollection 2017.

33.

Antibody response to human papillomavirus vaccination and natural exposure in individuals with Fanconi Anemia.

Mehta PA, Sauter S, Zhang X, Davies SM, Wells SI, Myers KC, Panicker G, Unger ER, Butsch Kovacic M.

Vaccine. 2017 Dec 4;35(48 Pt B):6712-6719. doi: 10.1016/j.vaccine.2017.10.015. Epub 2017 Oct 16.

34.

p16(INK4A) expression in invasive laryngeal cancer.

Hernandez BY, Rahman M, Lynch CF, Cozen W, Unger ER, Steinau M, Thompson T, Saber MS, Altekruse SF, Goodman MT, Powers A, Lyu C, Saraiya M.

Papillomavirus Res. 2016 Dec;2:52-55. doi: 10.1016/j.pvr.2016.03.001. Epub 2016 Mar 9.

35.

Prevalence of Human Papillomavirus Among Females After Vaccine Introduction-National Health and Nutrition Examination Survey, United States, 2003-2014.

Oliver SE, Unger ER, Lewis R, McDaniel D, Gargano JW, Steinau M, Markowitz LE.

J Infect Dis. 2017 Sep 1;216(5):594-603. doi: 10.1093/infdis/jix244.

36.

Pathobiology of human papillomaviruses in human immunodeficiency virus - Infected persons.

Krishnamurti U, Unger ER.

Semin Diagn Pathol. 2017 Jul;34(4):364-370. doi: 10.1053/j.semdp.2017.04.005. Epub 2017 Apr 6. Review.

PMID:
28549522
37.

Concordance Between Anal and Oral Human Papillomavirus Infections Among Young Men Who have Sex With Men.

Steinau M, Gorbach P, Gratzer B, Braxton J, Kerndt PR, Crosby RA, Unger ER, Markowitz LE, Meites E.

J Infect Dis. 2017 Jun 15;215(12):1832-1835. doi: 10.1093/infdis/jix232.

PMID:
28505338
38.

Prevalence of HPV in Adults Aged 18-69: United States, 2011-2014.

McQuillan G, Kruszon-Moran D, Markowitz LE, Unger ER, Paulose-Ram R.

NCHS Data Brief. 2017 Apr;(280):1-8.

39.

TPrevalence of HPV in Adults Aged 18-69: United States, 2011-2014.

McQuillan G, Kruszon-Moran D, Markowitz LE, Unger ER, Paulose-Ram R.

NCHS Data Brief. 2017 Apr;(280):1-8.

PMID:
28437239
40.

Description of a novel multiplex avidity assay for evaluating HPV antibodies.

Brady AM, Unger ER, Panicker G.

J Immunol Methods. 2017 Aug;447:31-36. doi: 10.1016/j.jim.2017.04.004. Epub 2017 Apr 19.

41.

Multi-Site Clinical Assessment of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (MCAM): Design and Implementation of a Prospective/Retrospective Rolling Cohort Study.

Unger ER, Lin JS, Tian H, Natelson BH, Lange G, Vu D, Blate M, Klimas NG, Balbin EG, Bateman L, Allen A, Lapp CW, Springs W, Kogelnik AM, Phan CC, Danver J, Podell RN, Fitzpatrick T, Peterson DL, Gottschalk CG, Rajeevan MS; MCAM Study Group.

Am J Epidemiol. 2017 Apr 15;185(8):617-626. doi: 10.1093/aje/kwx029. Erratum in: Am J Epidemiol. 2017 Jul 1;186(1):129.

42.

Prevalence of Genital Human Papillomavirus in Males, United States, 2013-2014.

Gargano JW, Unger ER, Liu G, Steinau M, Meites E, Dunne E, Markowitz LE.

J Infect Dis. 2017 Apr 1;215(7):1070-1079. doi: 10.1093/infdis/jix057.

PMID:
28170037
43.

Precision Medicine Requires Precision Laboratories.

Rajeevan MS, Li T, Unger ER.

J Mol Diagn. 2017 Mar;19(2):226-229. doi: 10.1016/j.jmoldx.2017.01.001. Epub 2017 Jan 24.

44.

Assessment of ME/CFS (Myalgic Encephalomyelitis/Chronic Fatigue Syndrome): A Case Study for Health Care Providers.

Brimmer DJ, Jones JF, Boneva R, Campbell C, Lin JS, Unger ER.

MedEdPORTAL. 2016 Dec 31;12:10527. doi: 10.15766/mep_2374-8265.10527.

45.

CDC Grand Rounds: Chronic Fatigue Syndrome - Advancing Research and Clinical Education.

Unger ER, Lin JS, Brimmer DJ, Lapp CW, Komaroff AL, Nath A, Laird S, Iskander J.

MMWR Morb Mortal Wkly Rep. 2016 Dec 30;65(50-51):1434-1438. doi: 10.15585/mmwr.mm655051a4.

46.

Universal Human Papillomavirus Typing Assay: Whole-Genome Sequencing following Target Enrichment.

Li T, Unger ER, Batra D, Sheth M, Steinau M, Jasinski J, Jones J, Rajeevan MS.

J Clin Microbiol. 2017 Mar;55(3):811-823. doi: 10.1128/JCM.02132-16. Epub 2016 Dec 14.

47.

Two vs Three Doses of Human Papillomavirus Vaccine: New Policy for the Second Decade of the Vaccination Program.

Markowitz LE, Meites E, Unger ER.

JAMA. 2016 Dec 13;316(22):2370-2372. doi: 10.1001/jama.2016.16393. No abstract available.

PMID:
27893046
48.

Evaluation of the Vulvar Cancer Histology Code Reported by Central Cancer Registries: Importance in Epidemiology.

Siegel DA, Wilson R, Wilkinson EJ, Gargano JW, Watson M, Hernandez BY, Goodman MT, Lynch CF, Unger ER, Saraiya M.

Arch Pathol Lab Med. 2017 Jan;141(1):139-143. doi: 10.5858/arpa.2015-0422-OA. Epub 2016 Oct 20.

49.

Prevalence of 9-Valent Human Papillomavirus Types by Race/Ethnicity in the Prevaccine Era, United States, 2003-2006.

Liu G, Unger ER, Hariri S, Steinau M, Markowitz LE.

Sex Transm Dis. 2016 Oct;43(10):633-6. doi: 10.1097/OLQ.0000000000000492.

PMID:
27631358
50.

Label-Free and Continuous-Flow Ferrohydrodynamic Separation of HeLa Cells and Blood Cells in Biocompatible Ferrofluids.

Zhao W, Zhu T, Cheng R, Liu Y, He J, Qiu H, Wang L, Nagy T, Querec TD, Unger ER, Mao L.

Adv Funct Mater. 2016 Jun 14;26(22):3990-3998. Epub 2015 Dec 7.

Supplemental Content

Loading ...
Support Center